Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: Obstet Gynecol. 2010 Sep;116(3):583–593. doi: 10.1097/AOG.0b013e3181e9e0ab
Desipramine-Placebo
Desipramine-Lidocaine
n Mean Baseline Mean Change n Mean Baseline Mean Change Regression P
32 2.03 −0.65±1.73 33 1.6 −0.52±0.71 Desipramine .38
Lidocaine .66
21 6.15 −2.07±2.31 21 5.92 − 1.72±1.99 Desipramine .86
Lidocaine .76
32 0.11 0.03±0.14 33 0.11 0.02±0.14 Desipramine .12
Lidocaine .81
32 19.59 − 8.07±10.23 34 19.97 −11.37±8.00 Desipramine .47
Lidocaine .15
Desip.–Lido. .03*
31 9.97 7.14±11.69 33 10.55 9.33±9.67 Desipramine .09
Lidocaine .51
32 1.19 − 0.34±0.75 34 0.97 −0.29±0.91 Desipramine .15
Lidocaine .44
32 13.21 − 5.48±7.8 30 14.78 −6.44±8.54 Desipramine .41
Lidocaine .42
Desip.–Lido. .03*
32 45.68 −14.87±19.67 33 42.77 −20.35±18.15 Desipramine .30
Lidocaine .48
28 87.54 −10.42±28.14 33 88.79 −5.48±26.17 Desipramine .45
Lidocaine .59
27 9.15 −3.33±5.26 32 9.76 −1.77±7.58 Desipramine .54
Lidocaine .41
32 21.59 − 8.08±15.24 34 17.82 − 7.62±12.01 Desipramine .13
Lidocaine .10
28 56.07 − 6.86±10.30 30 60.87 − 6.32±10.43 Desipramine .006
Lidocaine .97